HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 106 industry peers in the Health Care Providers & Services industry. HIMS has an excellent financial health rating, but there are some minor concerns on its profitability. HIMS shows excellent growth, but is valued quite expensive already. With these ratings, HIMS could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS has a Return On Assets of 17.81%. This is amongst the best in the industry. HIMS outperforms 98.11% of its industry peers.
HIMS has a Return On Equity of 26.44%. This is amongst the best in the industry. HIMS outperforms 92.45% of its industry peers.
HIMS's Return On Invested Capital of 10.98% is amongst the best of the industry. HIMS outperforms 86.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.81% | ||
| ROE | 26.44% | ||
| ROIC | 10.98% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (8.54%) than 90.57% of its industry peers.
The Operating Margin of HIMS (4.58%) is comparable to the rest of the industry.
HIMS has a better Gross Margin (79.45%) than 93.40% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 8.54% | ||
| GM | 79.45% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HIMS is still creating some value.
Compared to 1 year ago, HIMS has more shares outstanding
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 17.94. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HIMS (17.94) is better than 97.17% of its industry peers.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.94 |
ROIC/WACC1.22
WACC8.98%
2.3 Liquidity
HIMS has a Current Ratio of 1.79. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Current ratio of 1.79. This is in the better half of the industry: HIMS outperforms 66.04% of its industry peers.
HIMS has a Quick Ratio of 1.50. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Quick ratio (1.50) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 590.91%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.48% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.33%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)590.91%
EPS 3YN/A
EPS 5Y60.48%
EPS Q2Q%1000%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%95.45%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.61% on average over the next years. This is a very strong growth
EPS Next Y14.35%
EPS Next 2Y28.06%
EPS Next 3Y33.16%
EPS Next 5Y41.75%
Revenue Next Year57.32%
Revenue Next 2Y36.27%
Revenue Next 3Y31.97%
Revenue Next 5Y27.61%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 50.43, the valuation of HIMS can be described as expensive.
HIMS's Price/Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 44.10 indicates a quite expensive valuation of HIMS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (21.08), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.43 | ||
| Fwd PE | 44.1 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HIMS is valued a bit more expensive than 60.38% of the companies in the same industry.
60.38% of the companies in the same industry are more expensive than HIMS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.5 | ||
| EV/EBITDA | 66.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 33.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.51
PEG (5Y)0.83
EPS Next 2Y28.06%
EPS Next 3Y33.16%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.23
+0.28 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners79.43%
Inst Owner Change0%
Ins Owners11.03%
Ins Owner Change5.8%
Market Cap6.05B
Analysts69.09
Price Target44.78 (64.45%)
Short Float %27.64%
Short Ratio2.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)335.74%
Min EPS beat(2)4.62%
Max EPS beat(2)666.87%
EPS beat(4)4
Avg EPS beat(4)254.41%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.79%
EPS beat(12)10
Avg EPS beat(12)104.65%
EPS beat(16)11
Avg EPS beat(16)63.18%
Revenue beat(2)2
Avg Revenue beat(2)1.65%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)0.3%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)1.27%
Revenue beat(12)10
Avg Revenue beat(12)3.08%
Revenue beat(16)14
Avg Revenue beat(16)3.66%
PT rev (1m)3.79%
PT rev (3m)60.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.94%
EPS NY rev (1m)19.54%
EPS NY rev (3m)12.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.52%
Revenue NY rev (1m)1.6%
Revenue NY rev (3m)12.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.43 | ||
| Fwd PE | 44.1 | ||
| P/S | 4.1 | ||
| P/FCF | 30.5 | ||
| P/OCF | 24.09 | ||
| P/B | 12.69 | ||
| P/tB | 18.87 | ||
| EV/EBITDA | 66.99 |
EPS(TTM)0.54
EY1.98%
EPS(NY)0.62
Fwd EY2.27%
FCF(TTM)0.89
FCFY3.28%
OCF(TTM)1.13
OCFY4.15%
SpS6.65
BVpS2.15
TBVpS1.44
PEG (NY)3.51
PEG (5Y)0.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.81% | ||
| ROE | 26.44% | ||
| ROCE | 13.89% | ||
| ROIC | 10.98% | ||
| ROICexc | 28.7% | ||
| ROICexgc | 179.19% | ||
| OM | 4.58% | ||
| PM (TTM) | 8.54% | ||
| GM | 79.45% | ||
| FCFM | 13.43% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score7
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 308.7% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 296.65% | ||
| Profit Quality | 157.36% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 17.94 |
F-Score7
WACC8.98%
ROIC/WACC1.22
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)590.91%
EPS 3YN/A
EPS 5Y60.48%
EPS Q2Q%1000%
EPS Next Y14.35%
EPS Next 2Y28.06%
EPS Next 3Y33.16%
EPS Next 5Y41.75%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%95.45%
Revenue Next Year57.32%
Revenue Next 2Y36.27%
Revenue Next 3Y31.97%
Revenue Next 5Y27.61%
EBIT growth 1Y359.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.19%
EBIT Next 3Y91.04%
EBIT Next 5Y64.69%
FCF growth 1Y322.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y241.69%
OCF growth 3YN/A
OCF growth 5YN/A